ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0194

Depression Symptoms but Not Clinically Diagnosed Depression Predict Mortality in Rheumatoid Arthritis

Jose Felix Restrepo1, Inmaculada Del Rincon1 and Agustin Escalante1, 1University of Texas Health Science Center at San Antonio/ Department of Medicine/ Rheumatology, San Antonio, TX

Meeting: ACR Convergence 2020

Keywords: depression, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Friday, November 6, 2020

Title: RA – Diagnosis, Manifestations, & Outcomes Poster I: Multimorbidity

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Depression and depressive symptoms are common but under-recognized in rheumatoid arthritis (RA). Few studies have examined depression symptoms in RA patients compared to clinically diagnosed depression, and their role as mortality predictors. The objectives of the present study were to examine the prevalence of depression symptoms compared to clinically diagnosed depression and to examine the association of depression with mortality in RA patients.

Methods: We studied a cohort of RA patients who met the 1987 classification criteria, recruited from 1996 through 2011. All underwent a comprehensive clinical and psychosocial evaluation using standardized instruments. Depressive symptoms were measured with the Center for Epidemiologic Studies Depression Scale (CESD), adjusted for RA (CESD-RA) by eliminating items that may overlap with symptoms of RA.   We considered depression as present when the CESD score was ≥ 16. To quantify RA disease activity, we used the DAS28 ESR (DAS28). All deaths were confirmed with a death certificate. Multivariable logistic regression models were fit to examine the combined influence of independent variables on the outcome

Results: We studied 1328 RA patients, 981 of whom were women (74%).  A clinical diagnosis of depression was found in the medical records of 220 patients (17%), significantly fewer than the 361 (27%) with significant depression symptoms on the CESD (P < 0.0001).  There were 305 deaths during the study period. Of the patients who died, 31 had been diagnosed clinically with depression (10%), but 75 had significant depression symptoms on the CESD (26%). Patients with depression or significant depression symptoms were younger than patients without them, mean age 53 years (95% CI 52, 54) vs. 58 years (95% CI 57, 59), P < 0.0001, and more likely to be women, 82% vs. 69%, OR 1.97, (95% CI 1.48, 2.63), P < 0.0001. Patients with significant depression symptoms had greater disease activity than those without them, mean DAS28ESR 5.1 (95% CI 5.0, 5.3) vs. 4.0 (95% CI 3.9, 4.1), P < 0.001).

Logistic regression analysis adjusted for age and sex revealed that significant depression symptoms predicted all-cause mortality, OR 1.77 (95% CI 1.49, 2.12), P < 0.001, but clinically diagnosed depression did not.

Conclusion: Significant depression symptoms in RA are more frequent than depression diagnosed clinically, suggesting that some patients with depression may go undiagnosed. Depression symptoms predicted mortality in RA patients, while a clinical diagnosis of depression did not. Our findings suggest that strategies to improve the recognition of depression in RA should be studied further.

Figure. Significant depression symptoms were more frequent than clinically diagnosed depression in both patients who survived as well as in those who died (P < 0.001)


Disclosure: J. Restrepo, None; I. Del Rincon, None; A. Escalante, None.

To cite this abstract in AMA style:

Restrepo J, Del Rincon I, Escalante A. Depression Symptoms but Not Clinically Diagnosed Depression Predict Mortality in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/depression-symptoms-but-not-clinically-diagnosed-depression-predict-mortality-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/depression-symptoms-but-not-clinically-diagnosed-depression-predict-mortality-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology